We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical.

Company Growth (employees)
Hamburg, DE
Size (employees)
1,316 (est)+7%
Evotec was founded in 1993 and is headquartered in Hamburg, DE

Key People/Management at Evotec

Werner Lanthaler

Werner Lanthaler

Mario Polywka

Mario Polywka

Cord Dohrmann

Cord Dohrmann


Evotec Office Locations

Evotec has offices in Hamburg, South San Francisco, Branford, Princeton and in 5 other locations
Hamburg, DE (HQ)
7 Essener Bogen
Göttingen, DE
Toulouse, FR
195 Route d'Espagne
Branford, US
6 33 Business Park Dr
Princeton, US
3 College Rd E
South San Francisco, US
1 385 Oyster Point Blvd
Show all (9)

Evotec Financials and Metrics

Evotec Financials


Market capitalization (22-Mar-2017)

1.1 b

Closing share price (22-Mar-2017)

Evotec's current market capitalization is €1.1 b.
Show all financial metrics

Evotec Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AptuitJuly 30, 2017$300 m

Evotec Market Value History

Evotec's Web-traffic and Trends

Evotec Online and Social Media Presence

Evotec News and Updates

WCAS sells Aptuit to Evotec for about $300 mln

Welsh, Carson, Anderson & Stowe has sold drug developer Aptuit to Evotec AG for about $300 million. Cravath, PWC, Cain Brothers and William Blair advised Aptuit on the deal while Evotec's advisers included Freshfields Bruckhaus Deringer, KPMG, Mercer and Rothschild.

Evotec Company Life and Culture

You may also be interested in